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Abstract  
Purpose: To compare the enamel protection efficacy of a stabilized stannous fluoride dentifrice 
to a triclosan-containing sodium fluoride dentifrice using a 10-day in situ erosion model, in 
accordance with the American Dental Association Seal of Acceptance guidelines for enamel 
erosion control. Methods: In this single-center, double-blind, randomized, supervised-usage, 2-
treatment, 4-period, crossover study, healthy adult subjects were randomized to a treatment 
sequence involving the following products: a 0.454% stannous fluoride (1100 ppm F) dentifrice 
(Procter & Gamble) and a control dentifrice containing 0.243% sodium fluoride (1100 ppm F) 
and 0.3% triclosan (NaF/triclosan, Colgate-Palmolive).  Each study period consisted of 10 
treatment days.  Subjects wore an intra-oral appliance fitted with 2 polished human enamel 
samples for 6 hours per treatment day.  While wearing the appliance, subjects swished with their 
assigned dentifrice slurry for 60 seconds twice daily and with 250 ml orange juice over a 10-
minute period 4 times daily.  After 10 days, enamel specimens were removed and measured for 
surface loss using contact profilometry.  Results: Thirty-six subjects were enrolled and 33 
completed the study (mean age = 41.8 years).  The stannous fluoride dentifrice demonstrated 
90.3% less enamel loss than the NaF/triclosan dentifrice (P < 0.001) at Day 10, with median 
enamel loss of 0.279 µm and 2.877 µm, respectively.  Both products were well tolerated.  
Clinical Significance: The stannous fluoride dentifrice provided significantly greater protection 
against dental erosion relative to the NaF/triclosan dentifrice. 
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Introduction 
Dental erosion has gained considerable interest as a common clinical problem impacting both 
children and adults.1-6 Dental erosion is the loss of dental hard tissues by chemical action not 
involving bacteria.7  When observed in children and adolescents, the condition is reported to 
progress rapidly without intervention and can have long-term adverse effects on dentition and 
quality of life.6  The incidence of dental erosion is increasing globally8 and prevalence figures 
are high.6  A study of young European adults found that close to one-third showed signs of 
erosive tooth wear.1  
 
While the etiology of dental erosion is multifactorial, lifestyle influences like nutrition are 
thought to play a primary role, particularly in children and adolescents.6  Dietary acids contribute 
to demineralization and softening of tooth surfaces; once softened, these surfaces are highly 
susceptible to abrasion and attrition.3,9  The increase in consumption of acid-containing drinks 
among young people over the last several decades is well documented.10.11 Sugary, acidic drinks 
(soft drinks, energy drinks, sports drinks, and flavored water) were reported as the top calorie 
source among 14- to -18 year-olds in a study examining diets of children and adolescents.12  A 
comprehensive pH assessment found that 93% of nonalcoholic beverages commercially available 
in the US have erosive potential (pH <4).13  
 
A clinical diagnosis of dental erosion can be made based on the pattern of surface loss of enamel 
and/or dentin.  The Basic Erosive Wear Examination (BEWE), introduced by Bartlett and 
colleagues in 2008, is used to make such an assessment.14  The BEWE assigns severity scores 
between 0 (no erosive tooth wear) and 3 (hard tissue loss > 50% of surface) that can be 
transferred into risk levels to guide clinical management.  It would be ideal to identify erosion at 
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a much earlier stage by measuring surface changes, however at present this is difficult to do 
outside of the laboratory and techniques currently available are not suitable for a busy clinic.15 
Unlike caries, which can be reversed at early stages through remineralization, dental erosion is 
essentially irreversible and results in permanent damage to the tooth structure.16  Therefore, 
prevention is the preferred management approach.  Routine daily hygiene including dentifrice is 
an economical and convenient preventative strategy.3  Stannous fluoride is a unique fluoride 
compound that provides a broad range of benefits, including an anti-erosion benefit, when used 
in dentifrice.17-24 
 
The objective of this study was to determine the erosion protection efficacy of a new stabilized 
stannous fluoride smooth texture dentifrice formulation versus a marketed multi-benefit 
dentifrice formulated with sodium fluoride and triclosan (NaF/triclosan). 
 
Materials and methods 
Study population 
Healthy male and female volunteers aged 18 years or older were recruited from a UK dental 
school <<name removed for blinding>> from May to August 2017.  A screening visit was 
conducted up to one month before the study began.  Potential subjects received study 
information and agreed to delay elective dentistry and to refrain from participation in other 
product studies and from use of any non-study dentifrice or other oral hygiene products. All 
subjects provided written informed consent to participate.  A medical history and oral soft tissue 
examination was undertaken and subjects with dental erosion, aphthous ulcers, susceptibility to 
acid regurgitation, excessive gingival inflammation or severe periodontal disease were excluded 
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from the study. Thirty-six subjects who met all entrance criteria were enrolled in the study and 
scheduled to return for treatment.   
 
Ethical considerations 
Ethical approval was granted by the UK National Research Ethics Service (REC 
Ref:17/SW/007).  The study was conducted in accordance with Good Clinical Practice 
guidelines at a UK Dental School.   
 
Randomization 
Subjects were randomly assigned to one of four computer-generated treatment sequences 
(AABB, BBAA, ABBA or BAAB; letters indicate the two study treatments) that determined use 
of one of the two test dentifrices during each of the four study periods: A) a 0.454% stabilized 
stannous fluoride dentifrice (Crest® Pro-Health™ smooth texture formulation, Procter & Gamble, 
Cincinnati, OH, USA; 1100ppm fluoride); or B) a marketed dentifrice control containing 0.243% 
sodium fluoride and 0.3% triclosan/copolymer (Colgate® Total®, Colgate-Palmolive, New York, 
NY, USA; 1100ppm fluoride). 
 
In situ study design 
This single-center, double-blind, randomized, 2-treatment, 4-period crossover study used a 
modified version of a protocol previously published by Hooper et al.20 and was conducted in 
compliance with the American Dental Association Seal of Acceptance Guidelines for enamel 
erosion control.25  At the screening visit, subjects were given a non-treatment 0.32% sodium 
fluoride (1450 ppm fluoride) marketed dentifrice (Crest® Decay Protection dentifrice, Procter & 
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Gamble) and manual toothbrush (Oral-B® 35 manual toothbrush, Procter & Gamble).  Subjects 
were instructed to use both products at home instead of their normal oral care products twice 
daily (morning and evening) prior to and throughout the duration of the study, including 
treatment days and weekends. 
 
An alginate impression was taken and each subject was fitted with an upper palatal intra-oral 
appliance (Fig. 1) that retained two enamel samples derived from unerupted third molars from a 
Tooth Tissue Bank in the UK (NRES REC Ref, 16/NI/0192, HTA license 12200).  Subjects 
collected their appliances upon arrival at the clinical trials unit on treatment days and wore the 
appliance for approximately 6 hours on each of the 10 treatment days per study period. Test 
dentifrice treatment and erosive challenge occurred while subjects were wearing the appliance at 
the clinical site. 
 
The treatment and acid challenge schedule is shown in Figure 2. For test dentifrice treatment, 
clinical site personnel made dentifrice slurries by mixing three (3.0) grams of dentifrice with 10 
mL of water.  Subjects rinsed with the dentifrice slurry twice for 60 seconds and were blinded to 
the product identity of their assigned treatment.  The investigator and personnel performing and 
documenting surface profilometry assessments were also blinded to product identities and did 
not have access to the product dispensing room during treatments.  For the erosive challenge, 
subjects sipped 25 mL of orange juice (Sainsbury’s Supermarkets Ltd, London, UK) for one 
minute, swished, and expectorated.  This was repeated until the subject had swished 10 
consecutive times, for a total of 10 minutes, to expose the enamel samples to 250 mL of orange 
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juice.  Each study period consisted of 10 treatment days, with treatments being done only on 
weekdays (Monday – Friday) over a span of approximately 2 weeks. 
 
Preparation and analysis of enamel samples  
Before the study began, two baseline readings were obtained  for each enamel specimen using a 
calibrated contact surface profilometer (Mitutoyo (UK) Ltd, Andover, Hampshire UK).  
Readings were taken across a demarcated 2- to 3-mm area which was exposed to test treatments, 
either side of this area the enamel was protected by PVC tape.  To determine surface loss, 
enamel samples were remeasured (2 readings) at the end of the treatment phase of each study 
period using the same profilometry method in the same demarcated area.  Prior to the study, 
enamel specimens were soaked in sodium dichloroisocyanurate (20,000 ppm available chlorine) 
for a minimum of 24 hours before rinsing in copious amounts of deionized water.  Samples in 
each appliance were replaced with fresh human enamel samples at the beginning of each study 
period.  The procedures related to the acquisition, sterilization, preparation and analysis of 
human enamel test specimens have been described previously.22  
 
Determination of sample size 
A sample size of 36 subjects provided a power of at least 80% to detect a 2-sided 5% significant 
difference between the two treatments, assuming the natural log scale effect size was at least 
0.70 for this crossover design.   
 
Statistical methods 
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The primary efficacy measure was the amount of dental erosion that occurred after 10 days of 
treatment as assessed by profilometry.  For each subject, the average of four erosion 
measurements was recorded from each of the two enamel specimens at every visit.  Since the 
enamel loss distribution at Day 10 is right-skewed, the data were transformed using the natural 
log function before performing statistical analysis.  A general linear mixed model was used to 
compare treatments with a statistical model that included period and treatment as fixed effects, 
baseline as covariate, and subject as a random effect.  The carry-over effect was not statistically 
significant (P = 0.31) and was not included in the final analysis model.  Estimated means on the 
natural log scale from the statistical model were back-transformed using the exponential function 
(emean) to obtain the estimated medians or 50th percentiles on the original scale (µm), as well as 
the associated standard errors and/or 95% confidence intervals (CI).  Statistical comparisons 
were two-sided at a 5% significance level. 
 
The null hypothesis tested at Day 10 in this human in situ clinical study was that the mean dental 
erosion was equal between the two treatment dentifrices. The alternative hypothesis was that the 
mean dental erosion was not equal between the two treatment dentifrices. 
 
Results 
Thirty-six subjects were enrolled and 34 were randomized to treatment. Subjects ranged in age 
from 21 – 60 years (mean age 41.8 years). Twenty-four subjects (71%) were female.  The 
population was 76% Caucasian, 12% multi-racial, 9% Asian Indian, and 3% Asian Oriental 
(Table 1).  One subject voluntarily withdrew from the study after randomization.  Thirty-three 
subjects completed the study, and all study data were deemed evaluable.   
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The stabilized stannous fluoride dentifrice provided a statistically significant (P < 0.001) 90.3% 
better protection against erosion versus the NaF/triclosan, multi-benefit dentifrice at Day 10. The 
estimated enamel loss median (95% CI) was 0.279 µm (0.22, 0.35) for the stabilized stannous 
fluoride dentifrice and 2.877 µm (2.29, 3.61) for the NaF/triclosan dentifrice (Table 2, Fig. 3).  
Figure 4 shows a Distribution Box Plot of enamel loss by treatment, demonstrating marked 
differences in performance between the two test dentifrices at Day 10.   
 
Both dentifrices were well tolerated.  There were no adverse events reported. 
 
Discussion 
In this clinical trial, the stabilized stannous fluoride dentifrice resulted in significantly less 
enamel loss due to acid erosion relative to the dentifrice formulated with NaF/triclosan.  These 
findings corroborate previously published in vitro and in situ studies showing greater protection 
from erosion with use of stabilized stannous fluoride dentifrices versus dentifrices containing 
different fluoride compounds, including those formulated with sodium fluoride,18-20, 26 sodium 
monoflurophosphate,22,26 and amine fluoride.26  Professional organizations have also recognized 
stabilized stannous fluoride dentifrices for this benefit.27,28  The original  Crest Pro-Health 
formulation was the first dentifrice to obtain the American Dental Association Seal of 
Acceptance in the enamel erosion category,27  while an independent consensus statement issued 
by the European Federation of Conservative Dentistry acknowledged stannous fluoride 
dentifrices for their ability to reduce erosive tooth wear.28  
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Mechanistic studies demonstrate that stannous fluoride is unique among fluoride compounds in 
that it deposits a barrier layer onto enamel surfaces that is highly resistant to acids.26,29,30 The 
deposition starts with the first use.  This barrier increases with continued dentifrice use and is 
retained on the tooth surface for hours, providing extended protection against erosive acids. 
 
Stannous fluoride has inherent formulation challenges that must be overcome to provide its full 
range of therapeutic benefits in a dentifrice.  Namely, stannous fluoride must be delivered in a 
stable and bioavailable way.  Because of the distinct properties of stannous fluoride, not all 
dentifrices containing this ingredient can be presumed to be equal, and clinical evidence of 
benefit is essential. The stannous fluoride dentifrice evaluated in the current study has been 
formulated to circumvent these instability and bioavailability challenges.31   
 
Stabilized stannous fluoride dentifrice should be considered as part of overall prevention and 
management plan for patients at risk for dental erosion.28,31,32  In addition to providing benefits 
against dental erosion, stannous fluoride offers protection against a broad range of other 
therapeutic and cosmetic conditions, including dentinal hypersensitivity.31  Patients with dental 
erosion often experience pain and hypersensitivity33 and it is thought that dental erosion can both 
initiate and localize the lesion through loss of the tooth minerals that cover dentin tubules and the 
tubule opening.34  The protective surface layer formed by stabilized stannous fluoride that acts 
against erosion also inhibits sensitivity through sealing exposed dentin tubules.35  The ability of 
stannous fluoride dentifrice to provide anti-hypersensitivity benefits has been demonstrated in 
numerous clinical trials.36-37 
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The stannous fluoride dentifrice evaluated in the current study is the latest generation of Crest 
Pro-Health formulation advancements.  This new high-water formulation has improved esthetics 
and is a “smooth texture” variant that uses zinc citrate as the anti-calculus agent instead of 
sodium hexametaphosphate.  The new formulation shows anti-erosion benefit consistent with the 
earlier formulation, offering patients at risk for dental erosion, particularly those concerned about 
dentinal hypersensitivity, the broadest range of protection available in a dentifrice. In addition, 
the novel formulation studied here has the potential to improve compliance among patients who 
prefer a smooth texture dentifrice, allowing them to achieve the full range of possible benefits. 
 
Conclusion 
The stannous fluoride dentifrice evaluated in this randomized clinical trial demonstrated 
significantly greater erosion protection efficacy relative to the NaF/triclosan dentifrice. While 
lifestyle modifications are needed to curb the global increase in dental erosion, healthy dietary 
habits can be difficult for some patients to establish and maintain. A clinically proven stannous 
fluoride dentifrice is a convenient and economical way to incorporate a preventative strategy for 
dental erosion into patients’ daily oral hygiene regimen. 
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Figure 1. Intraoral appliance.  
Figure 2. Treatment and acid challenge schedule. 
Figure 3. Median change in enamel surface loss, showing 90.3% better protection for the 
stabilized stannous fluoride (SnF2) dentifrice compared to the NaF/triclosan dentifrice. 
Figure 4.  Box plot of data showing individual and averaged enamel loss data points for each of 
the two test dentifrices.  
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Figure 1. Intraoral appliance. 
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Figure 2. Treatment and acid challenge schedule.
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Figure 3.  Median change in enamel surface, showing 90.3% better protection for the stabilized 
stannous fluoride (SnF2) dentifrice compared to the NaF/triclosan dentifrice. 
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Figure 4.  Box plot of data showing individual and averaged enamel loss data points (m) for 
each of the two test dentifrices. 
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Table 1.  Study demographics. 
 
Table 2.  Enamel loss (µm) treatment comparison at Day 10. 
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Table 1.  Study demographics. 
 
Demographic Statistic or Category Value 
Age (Years) Mean (SD) 41.8 (12.35) 
 Min. – Max. 21 - 60 
Ethnicitya Asian Indian 3 (9%) 
 Asian Oriental 1 (3%) 
 Caucasian 26 (76%) 
 Multi-Racial 4 (12%) 
Gendera Female 24 (71%) 
 Male 10 (29%) 
aThe number and percent of subjects in each category 
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Table 2.  Enamel loss (µm) treatment comparison at Day 10. 
Treatment 
Original scale in µm 
estimated mediana 
(95% CI) 
Natural 
Log Scale 
Mean (SE) 
% less erosion vs. 
NaF/triclosan 
(P-value)b 
Stannous fluoride 0.279 (0.22, 0.35) -1.276 (0.114) 90.3% (P < 0.001) 
NaF/triclosan 2.877 (2.29, 3.61) 1.057 (0.114)  
aEstimated medians in μm were obtained by using the exponential function on the means from the natural logarithm 
scale (emean) and 95% CI were calculated; bCalculated from estimated medians in μm as 100% (NaF/triclosan – Stannous 
fluoride divided by NaF/triclosan). 
 
 
 
